Parenteral Bioavailability
Parenteral Bioavailability is the fraction of an administered drug dose that reaches systemic circulation unchanged following non-oral, typically injectable, administration, distinguishing it from oral bioavailability by circumventing gastrointestinal absorption and first-pass metabolism.
86
Publications
3.9K
Citations
312
Authors
111
Institutions
Publications per year
2017–2026
5
86
Qi Chen, Michael Graham Espey, Andrew Y. Sun et al. · Proceedings of the National Academy of Sciences · 2007 · 667 citations · Full text
Medicine, Biochemistry, Pharmacology +14
Cyclodextrins in drug carrier systems.
Kaneto Uekama, Masaki Otagiri · PubMed · 1987 · 300 citations
1–5 of 86
312
3
h-index
2
h-index
2
h-index
2
h-index
2 publications · 78 citations
2
h-index
1–5 of 312
111
National Cancer Institute
Bethesda, United States
3 h-index
4 publications
753 citations
Baxter (United States)
Deerfield, United States
3 h-index
9 publications
170 citations
Naval Medical Research Command
Silver Spring, United States
2 h-index
4 publications
54 citations

University of Toronto
Toronto, Canada
2 h-index
3 publications
48 citations

Walter Reed National Military Medical Center
Bethesda, United States
2 h-index
4 publications
54 citations
Universidad Complutense de Madrid
Madrid, Spain
2 h-index
10 publications
345 citations
National Institutes of Health
Bethesda, United States
2 h-index
5 publications
2.1K citations
University of Kansas
Lawrence, United States
2 h-index
3 publications
63 citations
1–8 of 111
Repository · 14 publications · 847 citations
13
h-index
5 publications · 253 citations
5
h-index
4 publications · 71 citations
4
h-index
3 publications · 132 citations
3
h-index
2 publications · 27 citations
2
h-index
1–5